Atlas Trials

Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design

Clinical trial NCT01945359 · COMPLETED

Trial details

NCT number
NCT01945359
Sponsor
Rocky Mountain MS Research Group, LLC
Status
COMPLETED
Study type
OBSERVATIONAL
Relapsing Remitting Multiple Sclerosis
Start date
2013-09-01
Primary completion
2014-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.